These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2647007)

  • 1. A placebo-controlled dose-response study of enprofylline in the maintenance therapy of asthma.
    Chapman KR; Bryant D; Marlin GE; Mitchell C; Ruffin R; Inouye T; Pedersen B; Koskinen S; Osen SS; Ringdal N
    Am Rev Respir Dis; 1989 Mar; 139(3):688-93. PubMed ID: 2647007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous treatment of asthmatic patients with enprofylline and theophylline.
    Laursen LC; Johannesson N; Weeke B
    Eur J Respir Dis; 1984 Oct; 65(7):504-8. PubMed ID: 6386511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison.
    Laursen LC; Eriksson G; Weeke B
    Respiration; 1986; 50(1):57-61. PubMed ID: 3523664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease.
    Chapman KR; Boucher S; Hyland RH; Day A; Kreisman H; Rivington R; Hodder RV; York EL; Abboud RT; Peters S
    J Allergy Clin Immunol; 1990 Feb; 85(2):514-21. PubMed ID: 2406328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term xanthine therapy of asthma. Enprofylline and theophylline compared. International Enprofylline Study Group.
    Chapman KR; Ljungholm K; Kallen A
    Chest; 1994 Nov; 106(5):1407-13. PubMed ID: 7956392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous enprofylline in the treatment of patients with acute asthma.
    Youngchaiyud P; Charoenratanakul S; Nana A; Wong E; Laxmyr L; Bamberg P
    J Int Med Res; 1990; 18(6):473-82. PubMed ID: 2292329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
    Lock SH; Kay AB; Barnes NC
    Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous enprofylline in asthma patients.
    Lunell E; Andersson KE; Persson CG; Svedmyr N
    Eur J Respir Dis; 1984 Jan; 65(1):28-34. PubMed ID: 6705855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enprofylline and theophylline on exercise-induced asthma.
    Laursen LC; Johannesson N; Weeke B
    Allergy; 1985 Oct; 40(7):506-9. PubMed ID: 3907395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.
    Busse WW; Chervinsky P; Condemi J; Lumry WR; Petty TL; Rennard S; Townley RG
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):457-63. PubMed ID: 9564797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and optimal dosing interval of the long-acting beta₂ agonist, vilanterol, in persistent asthma: a randomised trial.
    Sterling R; Lim J; Frith L; Snowise NG; Jacques L; Haumann B
    Respir Med; 2012 Aug; 106(8):1110-5. PubMed ID: 22520084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
    Busse WW; Bleecker ER; Bateman ED; Lötvall J; Forth R; Davis AM; Jacques L; Haumann B; Woodcock A
    Thorax; 2012 Jan; 67(1):35-41. PubMed ID: 21828231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
    Vilsvik JS; Persson CG; Amundsen T; Brenna E; Naustdal T; Syvertsen U; Storstein L; Källén AG; Eriksson G; Holte S
    Eur Respir J; 1990 Jan; 3(1):27-32. PubMed ID: 2311727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.